L-Asparaginase Monotherapy in Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of A Phase II Study

被引：0
|
作者：
Guo, Ye [1 ]
Ma, Xuejun [1 ]
Xia, Zuguang [1 ]
Xue, Kai [1 ]
Zhang, Qunling [1 ]
Hong, Xiaonan [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2730.2730
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2730
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type
    Kim, Hyun Jee
    Ock, Chan-Young
    Kim, Tae Min
    Lee, Sung Hee
    Lee, Ju-Yeun
    Jung, Sun Hoi
    Cho, Yoon Sook
    Kim, Miso
    Keam, Bhumsuk
    Kim, Dong-Wan
    Kim, Il Han
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2018, 50 (03): : 670 - 680
  • [22] Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
    Yamaguchi, Motoko
    Suzuki, Ritsuro
    Kwong, Yok-Lam
    Kim, Won Seog
    Hasegawa, Yuichi
    Izutsu, Koji
    Suzumiya, Junji
    Okamura, Takayuki
    Nakamura, Shigeo
    Kawa, Keisei
    Oshimi, Kazuo
    CANCER SCIENCE, 2008, 99 (05): : 1016 - 1020
  • [23] PEDIATRIC EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE
    Valiev, T.
    Kovrigina, A.
    Sholokhova, N.
    Tupitcin, N.
    Memtkevich, G. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 659 - 659
  • [24] Concurrent Chemoradiotherapy in Relapsed Extranodal NK/T-cell Lymphoma, Nasal Type: A Case Report
    Kacka, Duygu
    Ukimeraj, Aferdita
    Cavolli, Viola
    Sadiku, Shemsedin
    Hoda, Kaltrina
    Ukimeraj, Endrit
    Tahirbegolli, Iliriana Alloqi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S417 - S417
  • [25] Allogeneic hematopoietic stem cell transplant following chemotherapy containing L-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type
    Yokoyama, Hisayuki
    Yamamoto, Joji
    Tohmiya, Yasuo
    Yamada, Minami F.
    Ohguchi, Hiroto
    Ohnishi, Yasushi
    Okitsu, Yoko
    Fukuhara, Noriko
    Ohba-Ohtsuka, Rie
    Kohata, Katsura
    Ishizawa, Kenichi
    Kameoka, Junichi
    Harigae, Hideo
    LEUKEMIA & LYMPHOMA, 2010, 51 (08) : 1509 - 1512
  • [26] L-asparaginase and PEG-asparaginase: Activity in refractory T-cell lymphoma
    Price, C
    Siddique, S
    Dennis, R
    Robinson, S
    Pawade, J
    ANNALS OF ONCOLOGY, 2005, 16 : 189 - 189
  • [27] Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase:a multicenter retrospective study
    沈子园
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (04) : 233 - 234
  • [28] PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase
    Kwong, Yok-Lam
    Chan, Thomas S. Y.
    Tan, Daryl
    Kim, Seok Jin
    Poon, Li-Mei
    Mow, Benjamin
    Khong, Pek-Lan
    Loong, Florence
    Au-Yeung, Rex
    Iqbal, Jabed
    Phipps, Colin
    Tse, Eric
    BLOOD, 2017, 129 (17) : 2437 - 2442
  • [29] Intravascular large NK/T-cell lymphoma: a variant of extranodal NK/T-cell lymphoma, nasal type?
    Wenzhong Yu
    Ping Wang
    Hong Shen
    European Journal of Dermatology, 2019, 29 : 440 - 442
  • [30] Intravascular large NK/T-cell lymphoma: a variant of extranodal NK/T-cell lymphoma, nasal type?
    Yu, Wenzhong
    Wang, Ping
    Shen, Hong
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (04) : 440 - 442
12345